CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

HMN-154 25mg  | ≥96%

CSNpharm

HMN-154, a benzenesulfonamide anticancer compound, specifically binds with NF-YB and thymosin beta-10.

More Information Supplier Page

HMN-154 10mg  | ≥96%

CSNpharm

HMN-154, a benzenesulfonamide anticancer compound, specifically binds with NF-YB and thymosin beta-10.

More Information Supplier Page

HMN-214 25mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

HMN-214 1mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

HMN-214 5mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

HMN-214 50mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page

HMN-214 10mg  | ≥99%

CSNpharm

HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.

More Information Supplier Page